Bartosz Kuźlik

Bartosz Kuźlik

Auto-generated profile, based on publicly available information

Bartosz Kuźlik

Faculty of Medicine and Health Sciences, Andrzej Frycz Modrzewski Academy in Krakow

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 December 2023 in OphthaTherapy. Therapies in Ophthalmology
Verified
Journal Article
Open access
PDF file
ACAlicja Chmura-Hołyst
Alicja Chmura-Hołyst
KCKinga Czarnacka
Kinga Czarnacka
BŻBartłomiej Żaczek
Bartłomiej Żaczek
APAda Pandey
Ada Pandey
DPDominika Prokop
Dominika Prokop
ARAnna Maria Roszkowska
Anna Maria Roszkowska
Ophthalmic non-steroidal anti-inflammatory drugs are non-steroidal anti-inflammatory drugs used to treat or prevent eye inflammation. Their main action is to relieve symptoms such as pain, redness and swelling that can be caused by eye diseases, injuries or eye surgery. Non-steroidal anti-inflammatory drugs used in ophthalmology include substances such as diclofenac, ketorolac, bromfenac and nepafenac. So far, many studies have been published comparing the effectiveness of various systemic and local non-steroidal anti-inflammatory drugs. This work contains a comparative analysis of the above-mentioned substances in terms of their use and effectiveness in ophthalmology.

31 March 2023 in OphthaTherapy. Therapies in Ophthalmology
Verified
Journal Article
Open access
PDF file
KCKinga Czarnacka
Kinga Czarnacka
ACAlicja Chmura-Hołyst
Alicja Chmura-Hołyst
IAIsmael Alsoubie
Ismael Alsoubie
OCOliwia Cwalina
Oliwia Cwalina
APAda Pandey
Ada Pandey
ARAnna Maria Roszkowska
Anna Maria Roszkowska
Peripheral ulcerative keratitis is an inflammatory condition, usually crescent shaped and occurring in the corneal stromal region, where it is always associated with corneal stromal thinning. Peripheral ulcerative keratitis often occurs in the course of rheumatic diseases but is most commonly associated with rheumatoid arthritis. Peripheral ulcerative keratitis is also seen in granulomatosis with polyangiitis, polyarteritis nodosa, relapsing chondritis, and systemic lupus erythematosus. These diseases are analyzed in the article in relation to peripheral ulcerative keratitis with a discussion of individual treatment methods in specific cases.

30 June 2023 in OphthaTherapy. Therapies in Ophthalmology
Verified
Journal Article
Open access
PDF file
OCOliwia Cwalina
Oliwia Cwalina
APAda Pandey
Ada Pandey
DPDominika Prokop
Dominika Prokop
KCKinga Czarnacka
Kinga Czarnacka
MGMałgorzata Gawlak
Małgorzata Gawlak
MKMaciej Kozak
Maciej Kozak
Dry eye syndrome is a group of medical conditions that can be caused by many factors, as a result of which there is an abnormality in moisturizing of the eye surface by a tear film. One of the causes of this disorder is Sjögren’s syndrome, which is an autoimmune disease in which the body produces antibodies against its own proteins. The glands of external secretion, mainly lacrimal and salivary glands are damaged as a result of inflammation. Associated with this side effects, affect negatively and reduce the quality of life, which is why in the following article we present the available therapeutic options for patients suffering from ophthalmological manifestations of Sjögren’s syndrome.

27 December 2023 in OphthaTherapy. Therapies in Ophthalmology
Verified
Journal Article
Closed access
PDF file
DPDominika Prokop
Dominika Prokop
APAda Pandey
Ada Pandey
MGMałgorzata Gawlak
Małgorzata Gawlak
BKBartosz Kuźlik
Bartosz Kuźlik
KCKinga Czarnacka
Kinga Czarnacka
MKMaciej Kozak
Maciej Kozak
Keratitis and subsequent damage to the cornea resulting from infectious causes is one of the most serious problems facing ophthalmology today. One of the most common etiologies is fungal infection. Symptoms range from pain and visual deterioration, Wessely ring, inflammatory reaction in the anterior chamber or ropost. Diagnosis in addition to the classic medical and ophthalmologic examination consists of microscopic examination of scrapings, Gram examination combined with culture gives a 90% chance of detecting a fungal etiology. Good results are also observed with PCR testing, which helps speed up diagnosis. Treatment is time-consuming and has a high risk of complications. Two techniques are used to treat fungal infections of the cornea, surgical and pharmacological, such as the antifungal polyene antibiotics nystatin, natamycin, amphotericin B or thiazole derivatives like fluconazole and voriconazole. For filamentous fungi, natamycin 5% or voriconazole 1% are used at various intervals. Natamycin, despite the much poorer availability of the drug in countries such as Africa, has much better clinical results along with a lower risk of complications, as confirmed by the MUTT. A big problem also is subsequent bacterial superinfection, leading to the need for topical antibiotics. Surgical treatment is used in case of failure of pharmacotherapy, up to 4 weeks after the diagnosis of the disease, but it carries a high risk of complications. In the early stages of the disease, a new cross-linking technique can be considered, which is described as an alternative to direct antifungal or antibacterial treatment.